Tower Research Capital LLC (Trc) Xenon Pharmaceuticals Inc. Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,227 shares of XENE stock, worth $317,973. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,227

Previous 1,226 571.04%

Holding current value

$317,973

Previous $52,000 515.38%

% of portfolio

0.01%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$36.25 - $43.75 $253,786 - $306,293	7,001 Added 571.04%	8,227 $320,000
Q1 2024 May 15, 2024	BUY	$42.66 - $50.04 $9,043 - $10,608	212 Added 20.91%	1,226 $52,000
Q4 2023 Feb 13, 2024	BUY	$28.7 - $46.46 $23,447 - $37,957	817 Added 414.72%	1,014 $46,000
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $181,970 - $211,641	-5,327 Reduced 96.43%	197 $6,000
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $174,652 - $218,266	5,013 Added 981.02%	5,524 $212,000
Q1 2023 May 09, 2023	SELL	$33.46 - $40.35 $68,291 - $82,354	-2,041 Reduced 79.98%	511 $18,000
Q4 2022 Feb 10, 2023	SELL	$33.06 - $39.43 $54,482 - $64,980	-1,648 Reduced 39.24%	2,552 $101,000
Q3 2022 Nov 10, 2022	BUY	$30.79 - $39.82 $84,303 - $109,027	2,738 Added 187.28%	4,200 $151,000
Q1 2022 May 12, 2022	BUY	$25.09 - $33.13 $20,473 - $27,034	816 Added 126.32%	1,462 $44,000
Q4 2021 Feb 14, 2022	SELL	$15.6 - $35.4 $10,405 - $23,611	-667 Reduced 50.8%	646 $20,000
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $13,730 - $17,971	924 Added 237.53%	1,313 $20,000
Q2 2021 Aug 16, 2021	SELL	$16.81 - $20.0 $268 - $320	-16 Reduced 3.95%	389 $7,000
Q1 2021 May 17, 2021	SELL	$13.65 - $21.31 $12,871 - $20,095	-943 Reduced 69.96%	405 $7,000
Q4 2020 Feb 16, 2021	BUY	$9.49 - $16.04 $6,035 - $10,201	636 Added 89.33%	1,348 $21,000
Q3 2020 Nov 16, 2020	BUY	$10.82 - $13.35 $7,703 - $9,505	712 New	712 $8,000
Q2 2020 Aug 13, 2020	SELL	$10.21 - $14.9 $14,804 - $21,605	-1,450 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$8.08 - $17.57 $28,732 - $62,478	-3,556 Reduced 71.03%	1,450 $16,000
Q4 2019 Feb 07, 2020	BUY	$8.11 - $14.65 $16,252 - $29,358	2,004 Added 66.76%	5,006 $65,000
Q3 2019 Nov 05, 2019	BUY	$8.74 - $10.51 $26,237 - $31,551	3,002 New	3,002 $27,000
Q2 2019 Aug 13, 2019	SELL	$8.51 - $10.75 $15,913 - $20,102	-1,870 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$6.39 - $10.42 $10,262 - $16,734	1,606 Added 608.33%	1,870 $19,000
Q4 2018 Feb 14, 2019	BUY	$5.61 - $12.62 $920 - $2,069	164 Added 164.0%	264 $2,000
Q3 2018 Nov 13, 2018	BUY	$9.0 - $14.9 $900 - $1,490	100 New	100 $1,000
Q4 2017 Feb 09, 2018	SELL	$2.2 - $3.25 $715 - $1,056	-325 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.25 $796 - $1,056	325	325 $1,000

Others Institutions Holding XENE

# of Institutions

221

Shares Held

69.6M

Call Options Held

59.7K

Put Options Held

60.7K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.41B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Xenon Pharmaceuticals Inc. Transaction History